In vivo targeting capacities of different nanoparticles to prostate tissues based on a mouse model of chronic bacterial prostatitis [PDF]
Frontiers in Bioengineering and Biotechnology, 2022 Chronic bacterial prostatitis usually occurs in men and seriously affects the quality of life of patients. The efficacy of chronic bacterial prostatitis treatment is limited by the difficulty for free drugs (e.g., antibiotics) to penetrate the prostate ...
Ruimin Hu +7 more
doaj +4 more sources
Ceftriaxone for the Treatment of Chronic Bacterial Prostatitis: A Case Series and Literature Review [PDF]
Antibiotics, 2022 Chronic bacterial prostatitis is increasingly difficult to treat due to rising antimicrobial resistance limiting oral treatment options. In this case series, 11 men with CBP (including patients with urological comorbidities) due to multi-resistant E ...
Sander G. Kuiper +6 more
doaj +2 more sources
Chronic bacterial prostatitis: efficacy of short-lasting antibiotic therapy with prulifloxacin (Unidrox®) in association with saw palmetto extract, lactobacillus sporogens and arbutin (Lactorepens®) [PDF]
, 2014 Bacterial prostatitis (BP) is a common condition accounting responsible for about 5-10% of all prostatitis cases; chronic bacterial prostatitis (CBP) classified as type II, are less common but is a condition that significantly hampers the quality of life,
D. V. Matei +8 more
core +6 more sources
Chronic Bacterial Prostatitis: Enterococcal Disease? [PDF]
Clinical Infectious Diseases, 2011 n ...
Vittorio Magri +2 more
openalex +4 more sources
The Role of Butirprost® as an Adjuvant in Enhancing the Effect of Antibiotics in Patients Affected by Chronic Bacterial Prostatitis: A Randomized Prospective Trial [PDF]
MedicinaBacterial prostatitis (BP) is a common prostatic infection characterized by pain and urinary symptoms, often with negative bacterial cultures from prostatic secretions.
Felice Crocetto +20 more
doaj +2 more sources
CLINICAL FEATURES OF A CHRONIC BACTERIAL PROSTATITIS AGAINST DEFICIENCY OF TESTOSTERONE
Вестник урологии, 2013 The study involved 124 patients aged 20-45 years with a diagnosis of chronic bacterial prostatitis. In 37% of patients with chronic bacterial prostatitis testosterone was below the standard indicators.
H. S. Ibishev +2 more
doaj +2 more sources
Oral Fosfomycin for the Treatment of Acute and Chronic Bacterial Prostatitis Caused by Multidrug-Resistant Escherichia coli [PDF]
Canadian Journal of Infectious Diseases and Medical Microbiology, 2018 Acute and chronic bacterial prostatitis in outpatients is commonly treated with oral fluoroquinolones; however, the worldwide dissemination of multidrug-resistant (MDR) Escherichia coli has resulted in therapeutic failures with fluoroquinolones.
George G. Zhanel +2 more
doaj +2 more sources
Acta Biomedica Scientifica, 2017 The article represents a description for microbiocenosis of isolated prostate secret. The initial samples were taken on the territory of the Irkutsk region from men diagnosed with chronic bacterial prostatitis in the acute stage.
T. V. Tunik +4 more
doaj +3 more sources
The use of Lactobacillus casei DG® prevents symptomatic episodes and reduces the antibiotic use in patients affected by chronic bacterial prostatitis: results from a phase IV study. [PDF]
World J Urol, 2021 Cai T +10 more
europepmc +3 more sources
Anti-Inflammatory and Antimicrobial Effects of a Novel Herbal Formulation (WSY-1075) in a Chronic Bacterial Prostatitis Rat Model [PDF]
The World Journal of Men's Health, 2016 Purpose: The aim of this study was to investigate the anti-inflammatory and anti-oxidative effects of a multi-herbal formula known as WSY-1075 in the treatment of chronic bacterial prostatitis in a rat model. Materials and Methods: Experimental chronic
Jung Woo Park +12 more
doaj +2 more sources